Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis C virus non-structural protein NS4A (NS4A) is a small, 54-amino-acid polypeptide that serves as an essential cofactor for the NS3 serine protease [1.1.1, 1.3.1]. Together, they form the NS3-NS4A complex, which is responsible for the proteolytic processing of the HCV polyprotein into functional units required for viral replication [1.1.2, 1.3.3]. Beyond its role in proteolysis, NS4A anchors the NS3-NS4A complex to the endoplasmic reticulum (ER) and mitochondrial membranes, enhances NS3 helicase activity, and regulates NS5A phosphorylation [1.2.1, 1.3.2]. The NS3-NS4A complex also plays a critical role in immune evasion by cleaving host proteins like MAVS and TRIF, thereby disrupting interferon signaling [1.3.3]. Due to its central role in the viral life cycle, the NS3-NS4A complex is a primary target for Direct-Acting Antivirals (DAAs), specifically NS3/4A protease inhibitors such as glecaprevir and voxilaprevir [1.3.3, 1.3.4]. These drugs bind to the protease active site or the NS3-NS4A interface, effectively halting viral replication and leading to high rates of sustained virologic response in patients with chronic hepatitis C [1.1.1, 1.3.4].
Inhibition of the NS3-NS4A serine protease complex, preventing the cleavage of the viral polyprotein into functional non-structural proteins, thereby halting viral replication.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus non-structural protein NS4A (NS4A).